Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA

OBJECTIVE: The aim was to assess the long-term safety and efficacy of certolizumab pegol over 4 years of continuous treatment in patients with axial spondyloarthritis (axSpA), including both AS and non-radiographic (nr-) axSpA. METHODS: RAPID-axSpA was a phase 3 randomized trial, double blind and pl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Oxford)
Main Authors: van der Heijde, Désirée, Dougados, Maxime, Landewé, Robert, Sieper, Joachim, Maksymowych, Walter P., Rudwaleit, Martin, Van den Bosch, Filip, Braun, Jürgen, Mease, Philip J., Kivitz, Alan J., Walsh, Jessica, Davies, Owen, Bauer, Lars, Hoepken, Bengt, Peterson, Luke, Deodhar, Atul
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850296/
https://ncbi.nlm.nih.gov/pubmed/28498975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex174
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados